top of page
sam shrivastava excutive chairman, founder, and CEO at IBIS therapeutics biotech entrepreneur
ibis therapeutics fingerprint logo
Our Molecular Fingerprint™ Platform evaluates all possible interactions between diverse arrays of drug candidates with the largest curated collection of both disease-modifying and toxicity-causing protein targets.

Explore

About

Contact Us

USF Connect Building

3802 Spectrum Blvd, Suite146

Tampa, FL 33612

©2022 IBIS Therapeutics

bottom of page